JAIC
PRPH

Josh Arnold Investment Consultant’s ProPhase Labs PRPH Stock Holding History

Josh Arnold Investment Consultant’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,000
Closed -$100K – 21
2025
Q1 		$100K Buy
+25,000
New +$115K 0.08% 19

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Josh Arnold Investment Consultant's PRPH Position: Q2 2025 in Review

Josh Arnold Investment Consultant sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 25,000 shares — an estimated $100K sold.

Josh Arnold Investment Consultant first reported a position in PRPH in Q1 2025 and held it in 1 quarter. The position peaked at $100K in Q1 2025. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Josh Arnold Investment Consultant reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Josh Arnold Investment Consultant sold 25,000 ProPhase Labs shares in Q2 2025, an estimated $100K.
  • Josh Arnold Investment Consultant first reported a position in ProPhase Labs in Q1 2025 and held it in 1 quarter.
  • Josh Arnold Investment Consultant's ProPhase Labs position peaked at $100K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Josh Arnold Investment Consultant's 13F filing for Q2 2025, filed 14 Aug 2025.